Sotera Health Announces Third-Quarter 2026 Earnings Release Date
Sotera Health (SHC) plans to release its third-quarter 2026 financial results before the market opens on November 3, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Sotera Health (SHC) plans to release its third-quarter 2026 financial results before the market opens on November 3, 2026. The results cover the quarter ended September 30, 2026. Management will host a conference call at 9:00 a.m. Eastern Time that day. A live webcast and accompanying materials will be available through the company’s Investor Relations website, with a replay available later that day.
Key Figures
- Earnings release date
- November 3, 2026
- Q3 2026 results, before market open
Key Terms
ethylene oxide technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
CLEVELAND, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the third quarter ended September 30, 2026 before the market opens on Tuesday, November 3, 2026. Following the release, management will host a conference call at 9:00 a.m. Eastern Time to discuss the Company’s operating and financial results.
A live webcast of the conference call and accompanying materials can be accessed via the Investor Relations section of the Company’s website at Presentation & Events | Sotera Health. A replay of the webcast will be available later in the day on November 3.
Updates on recent developments in matters relevant to investors can be found on the Investor Relations section of the Sotera Health website at Investor Relations | Sotera Health. For developments related to Ethylene Oxide, updates can be found at Ethylene Oxide | Sotera Health.
About Sotera Health
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®.
| Contacts | |
| Jason Peterson Vice President, Investor Relations IR@soterahealth.com | |
| Kristin Gibbs Chief Marketing Officer, Sotera Health kgibbs@soterahealth.com |
Source: Sotera Health Company
